Eli Lilly recently surpassed a $1 trillion market capitalization amid increased demand for its weight-loss innovation. Kevin Gade, COO at Bahl & Gaynor, noted that the milestone reflects the significant role the company’s innovations have played in the healthcare market.
Kevin T. Gade
Chief Operating Officer
Principal & Portfolio Manager
[email protected]
To read more about this historic milestone, please follow the link HERE to the full article.